Mycobacterial shuttle vectors contain dual origins of replication for growth in both 18
beginning of recorded human history (9, 14, 15). Every year 12-14 million people suffer 40 from active disease, and of these, 2 million die. For those apparently cured from such 41 syndromes as tuberculous (TB) meningitis, more than 60% are likely to die within 5 years, 42
and close to half of those that survive will develop permanent medical problems (32, 38) . 43
While therapy for TB has been life saving, preventing infections and disease progression 44 would be much more effective. M. avium and M. leprae are two additional mycobacterial 45 species of concern for the human population, with immunocompromised patients being 46 very susceptible to M. avium. There are no broadly effective vaccines for mycobacterial 47
infections. An attenuated derivative of M. bovis (the Bacille Calmette-Guerin strain or 48 BCG) is the most commonly used vaccine for TB. Yet, BCG has limited effectiveness in 49 newborns and children, is not protective in adults, and is thus not currently recommended 50 infection by fluorescent microscopy. The murine Il-6-promoter was amplified from genomic 162 DNA (extracted from tail biopsies from C57BL/6 mice) with standard PCR reactions (4). 163
AseI and AgeI sites were included at the 5' and 3' ends, respectively. The resulting 164 fragment was subcloned into an AseI/AgeI digested pEGFP-N1 plasmid (Clontech, BD 165
Biosciences, Inc). The new pmIl6-gfp plasmid was electroporated into J774A.1 166 macrophages. Individual clones were isolated by G418 selection, with one clone (J774A.1 167 mIL-6gfp #3) used for the studies described herein. This clone was maintained in the 168 aforementioned DMEM media supplemented with 1 mg/ml of G418. These cells were 169 (Fig. 1B) . The over-expression of GFP at different 207 levels had no effect on the E. coli growth, as similar CFUs/ml were obtained with control 208 and high GFP expressing clones ( (Fig. 1D ). There was a 7-, 9-, and 190-fold increase in 211 the MFI, respectively (Fig. 1D , p < 0.0005). There was no impact of these high-level 212 protein expression cassettes on the mycobacterial growth characteristics (Fig. 1E) . These 213 results demonstrate that the kanamycin promoter/gene cassette was the most effective for 214 GFP expression in both E. coli and M. smegmatis, with the levels detected in the 215 mycobacterial species 21-fold higher than standard E. coli strains (Figs. 1B &1D) . Given 216 the success of the kanamycin cassette, the parental pSUM36 vector was redesigned to 217 facilitate directional cloning. The HindIII and BamHI restriction sites were flipped and the 218 optimized translation initiation site was cloned at the 3' end of the kanamycin cassette 219 (pSUM36-kan-MCS2). While this new cloning vector resulted in an equivalent GFP 220 expression in E. coli as in the pSUM-kan-MCS1 plasmid, it provided a 2-fold higher level of 221 fluorescence in M. smegmatis than that achieved with pSUM-kan-MCS1 (Figs. 1B, 1D) . 222
The experiments were repeated in M. avium. A 500-fold increase in fluorescence was 223 detected over the control vector transformed M. avium clones, with limited impact on 224 mycobacterial growth (Fig. 1F-G) . consistent with the loss of membrane integrity. In contrast, the macrophages exhibited a 242 normal viability, even after infection with the different mycobacterial clones, independent of 243 GFP expression ( Fig. 2A, middle panel) . Light field images revealed evenly distributed 244 macrophage monolayers that were unaffected by the type of expression vector used (Fig.  245 2A, lower panel). These experiments indicated that the pSUM vectors with the kanamycin 246 cassette, coupled to an optimized translational initiation site, were ideal for achieving high-247 level protein expression in infected cells. To determine if these vectors were suitable for 248 other mycobacterial species, M. avium was transfected with pSUM-kan-MCS2-gfp. The 249 resulting clones were used to infect macrophages at MOI's of 3:1, 10:1, and 30:1 (Fig. 2B) . 250
As with M. smegmatis, the M. avium-GFP clones were highly visible in the infected 251 macrophages (Fig. 2B, upper panel) . The infected macrophages exhibited similar 252 viabilities at the different MOI's, as determined by LIVE/DEAD staining and bright field 253 images (Fig. 2B, middle and lower panel) . M. marinum clones expressing GFP have a 254 reduced virulence in zebra fish infection models (31). To determine if the M. smegmatis 255 GFP over-expressing clones were attenuated in the macrophages, the CFU/ml were 256 on September 23, 2017 by guest http://aem.asm.org/ Downloaded from 14 calculated after lysing the infected macrophages. While there were variations in the 257 CFU/ml calculated for the different M. smegmatis clones, we did not detect statistically 258 significant differences between the GFP low and high expressing clones (Fig. 2C) . Given 259 our ability to achieve high level GFP expression in mycobacteria, we next assessed 260 whether these would be suitable for detecting the location of mycobacteria in infected 261 macrophages. Confocal microscopy analyses of the infected macrophages revealed 262 distinct mycobacterial morphologies when comparing M. smegmatis and M. avium. M. 263 smegmatis cells were seen as extended filaments that overlapped with the phagolysosome, 264 as detected by LAMP staining. This pattern was distinct from the M. avium cells, which 265 appeared clustered in discrete, rounded foci, that again were in the proximity with 266 lysosomal granules (LAMP) (Fig. 3A versus B) . The differences between M. avium and M. 267 smegmatis were clearly revealed with multiple z-plane stacks, provided in Supplemental 268
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High level ESAT-6 expression is insufficient to suppress innate inflammatory 271 pathways in macrophages. 272
To further examine the usefulness of the modified pSUM vectors for studying high-level 273 protein expression, the gfp gene was replaced with esat-6 (Fig. 1A) . ESAT-6 is normally 274 secreted via the ESX-1 secretion system, and is proposed to inhibit Toll-like receptor 275 signaling (33, 34, 42). To compare the expression levels of ESAT-6, extracts were 276 prepared from E. coli and M. smegmatis clones containing either the parental vector or the 277 pSUM-kan-MCS2-esat-6 expression vector (Fig. 4A) . The M. smegmatis-esat-6 was 278 grown in 7H9 media, culture conditions that prevent ESAT-6 secretion that would enable 279 on September 23, 2017 by guest http://aem.asm.org/ Downloaded from 15 us to detect the protein in mycobacterial lysates (13) . Western immunoblotting confirmed 280 that ESAT-6 was specifically expressed at high levels in the M. smegmatis clones 281 containing the enhanced protein expression plasmid (Fig. 4A, lane 6, 7) . ESAT-6 was 282 almost undetectable in the E. coli extracts, consistent with the lower levels of GFP 283 expression in E. coli versus the mycobacterial strains (Fig. 4A, lane 3, 4) . Even though M. 284 smegmatis was grown in media that does not allow ESAT-6 secretion, it was unknown 285 whether ESAT-6 would be released with the high-level protein expression vector (13) . To 286 determine whether ESAT-6 was released into the media, M. smegmatis cultures were 287 harvested after 3 days of culture. A polyclonal antisera was used to precipitate ESAT-6 288 from the clarified and filtered culture supernatant. This polyclonal antisera precipitated an 289 exogenous source of pure ESAT-6, produced in E. Coli, that was added directly into 1.0 ml 290 and 50 ml of lysis buffer, as determined by subsequent Western immunoblotting (Fig. 4B,  291   lanes 1-2) . In contrast, no endogenously produced ESAT-6 was precipitated from the 292 clarified M. smegmatis culture supernatants (Fig. 4B, lane 3) . To confirm that the culture 293 supernatant did not contain a protease activity that might have degraded ESAT-6, a 294 separate immunoprecipitation was performed in which pure ESAT-6 was spiked into the 295 culture supernatant. This exogenously added ESAT-6 was detected in the precipitate (Fig.  296 
4B, lane 4). Taken together, these findings indicate that the modified pSUM vectors 297
provided for high-level protein expression in diverse mycobacterial species. To monitor innate cell activation, a murine Il-6 promoter (600 bp) was cloned upstream of 304 GFP, replacing the standard cytomegalovirus promoter (Fig. 4C) (4) . This construct was 305 used to generate stable macrophage cell lines (J774A.1) expressing GFP under the 306 control of IL-6 promoter. One subclone (J774A.1 IL-6-gfp #3) exhibited a > 7-fold increase 307 in GFP expression after the cells were cultured for 24 h in the presence of LPS. A dose 308 response curve revealed that the cells were sensitive to LPS concentrations as low as 1 309 ng/ml (data not shown). These J774A.1 IL-6 reporter cells were infected with M. 310 smegmatis at MOIs of 3:1, 10:1, and 30:1 (Fig. 4D) . GFP was detected in the 311 macrophages 24 h post-infection at all three MOIs, with the optimal signal detected at an 312 MOI of 30:1. Such experiments established the usefulness of this reporter cell line to 313 monitor an innate inflammatory response upon exposure to mycobacteria. 314
Previous work has shown that pathogenic mycobacteria cause an attenuated 315 inflammatory response compared to non-pathogenic strains (7). This is partly attributed to 316 the release of ESAT-6 by strains such as M. tuberculosis (33). M. smegmatis clones that 317 expressed high levels of ESAT-6 were tested for their ability to inhibit the IL-6-promoter 318 driven GFP expression in J774A.1 cell lines. Macrophages were infected at MOIs of 3:1, 319 10:1, and 30:1 with either the M. smegmatis parental cells or the clones expressing ESAT-320 6. The levels of GFP, as measured by flow cytometry, were indistinguishable at each MOI 321 tested, regardless of whether the macrophages were infected with M. smegmatis clones 322 lacking or containing the kan-MCS2-esat-6 expression vector (Fig. 5A) . These 323 experiments suggested one of two possibilities. First, ESAT-6 needed to be secreted to 324 on September 23, 2017 by guest http://aem.asm.org/ Downloaded from suppress innate inflammatory pathways. Second, ESAT-6 does not inhibit Il-6 promoter 325 activity. To address these possibilities, pure ESAT-6 was added to the Il-6-GFP 326 macrophage reporter cell line, either alone or prior to the addition of LPS or M. smegmatis 327 (Fig. 5B) . Unexpectedly, pure ESAT-6 directly activated the Il-6-GFP reporter cell line, as 328 measured by the increased fluorescence intensity (Fig. 5B, upper panel) . Moreover, the 329 activation of the IL-6 reporter cell line was stronger in the LPS stimulated cultures when 330 ESAT-6 was supplemented. The macrophage cell line was clearly activated, as revealed 331 with an increased forward and side scatter (Fig. 5B, lower panel) . In fact, the fluorescence 332 levels were highest in the presence of pure ESAT-6 compared to LPS (Fig. 5C ). The 333 ability of ESAT-6 to induce this strong inflammatory response was reduced when 334 combined with M. smegmatis, matching the GFP expression when the macrophages were 335 exposed to the mycobacteria. We speculate this is due to ESAT-6 sequestration by the 336 mycobacteria. To examine if the activation of the IL-6 pathway correlated with ESAT-6 337 levels, a dose-response assay was undertaken. Starting at 12 μg/ml of pure ESAT-6, a 338 serial dilution indicated that levels as low as 50 ng/ml induced GFP expression around 25-339 fold (Fig. 5D) . These experiments indicate that ESAT-6 can stimulate certain components 340 of the innate inflammatory response. overexpressing ESAT-6 to determine how ESAT-6 suppresses innate inflammatory 382 pathways. Importantly, this intracellular form of ESAT-6 did not suppress an innate 383 inflammatory response, as measured via the activation of the IL-6 promoter through either 384 LPS or M. smegmatis. Since a previous report suggested that ESAT-6 must be released 385 in a secreted form to attenuate Toll-like receptor signaling, we tested pure ESAT-6 in our 386 IL-6 reporter assay (33). The ESAT-6 was purified using established procedures that 387 eliminate contaminating LPS. Surprisingly, ESAT-6 strongly activated the IL-6 dependent 388 
